A phase 3, multi-center trial of oral, sustained-release fampridine (4-aminopyridine) in multiple sclerosis

被引：0
|
作者：
Goodman, Andrew
Schwid, Steven
Brown, Theodore
Krupp, Lauren
Schapiro, Randall
Marinucci, Lawrence
Cohen, Ron
Blight, Andrew
机构：
来源：
NEUROLOGY | 2007年 / 68卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A206 / A206
页数：1
相关论文
共 50 条
  • [31] Normal central motor conduction time before therapy initiation predicts non-response to sustained-release oral fampridine in patients with multiple sclerosis
    Zeller, D.
    Reiners, K.
    Braeuninger, S.
    Buttmann, M.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 544 - 544
  • [32] Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine
    Rossini, PM
    Pasqualetti, P
    Pozzilli, C
    Grasso, MG
    Millefiorini, E
    Graceffa, A
    Carlesimo, GA
    Zibellini, G
    Caltagirone, C
    MULTIPLE SCLEROSIS, 2001, 7 (06): : 354 - 358
  • [33] Sustained-release oral dalfampridine appears to have no impact on upper extremity function in people with multiple sclerosis: a randomized controlled trial
    Menascu, Shay
    Frid, Lior
    Kalron, Alon
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2025, 18
  • [34] A COMPARISON BETWEEN 4-AMINOPYRIDINE AND 3,4-DIAMINOPYRIDINE IN THE TREATMENT OF MULTIPLE-SCLEROSIS
    BERTELSMANN, FW
    POLMAN, CH
    VANDIEMEN, HAM
    DEWAAL, R
    KOETSIER, JC
    ANNALS OF NEUROLOGY, 1992, 32 (02) : 256 - 256
  • [35] 4-AMINOPYRIDINE IS SUPERIOR TO 3,4-DIAMINOPYRIDINE IN THE TREATMENT OF PATIENTS WITH MULTIPLE-SCLEROSIS
    POLMAN, CH
    BERTELSMANN, FW
    DEWAAL, R
    VANDIEMEN, HAM
    UITDEHAAG, BMJ
    VANLOENEN, AC
    KOETSIER, JC
    ARCHIVES OF NEUROLOGY, 1994, 51 (11) : 1136 - 1139
  • [36] A Multi-Center Randomized Clinical Trial of Donepezil To Treat Memory Impairment in Multiple Sclerosis
    Krupp, Lauren B.
    Christodoulou, Christopher
    Melville, Patricia
    Scherl, William F.
    Pai, Ling-Yu
    Benedict, Ralph
    Goodman, Andrew D.
    Rizvi, Syed
    Schwid, Steven R.
    Weinstock-Guttman, Bianca
    Westervelt, Holly J.
    Wishart, Heather
    NEUROLOGY, 2010, 74 (09) : A294 - A294
  • [37] Rapid titration with oral sustained-release morphine plus subcutaneous morphine in a multi-center, randomized control study of cancer patients with moderate to severe cancer pain
    Sun, Yu
    Wei, Hao
    Yu, Min
    Zheng, Rujun
    Li, Junying
    Fu, Yan
    Zheng, Yuzhu
    Zhang, Xi
    Shou, Feng
    Zhou, Jin
    Yao, Wenxiu
    Chen, Ping
    Liu, Dingyi
    Jia, Yuming
    Fu, Yu
    Wang, Yan
    Zhu, Jiang
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (11) : 1303 - 1310
  • [38] Clinical Correlations of Free Water Diffusion in Multiple Sclerosis in a Multi-Center, Clinical Trial Setting
    By, Samantha
    Houde, Jean Christophe
    Pachai, Chahin
    Maltais, Loika
    Tagge, Ian
    Torres, Jorge
    Huang, Sujuan
    Bradley, Daniel
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 542 - 543
  • [39] Prolonged-Release Fampridine Induces Sustained Clinically Meaningful Improvements in Walking Ability in People with Multiple Sclerosis: Results from the ENHANCE Trial
    Hobart, Jeremy
    Ziemssen, Tjalf
    Feys, Peter
    Linnebank, Michael
    Goodman, Andrew
    Farrell, Rachel
    Englishby, Veronica
    McNeill, Manjit
    Chang, Ih
    Mehta, Lahar
    Elkins, Jacob
    NEUROLOGY, 2017, 88
  • [40] 4-AMINOPYRIDINE IMPROVES NEUROLOGICAL DEFICITS IN MULTIPLE-SCLEROSIS PATIENTS - DEMONSTRATION IN A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    BEVER, CT
    YOUNG, D
    ANDERSON, P
    KRUMHOLZ, A
    CONWAY, K
    LESLIE, J
    EDDINGTON, N
    PLAISANCE, K
    PANITCH, H
    JOHNSON, K
    ROSENBERG, L
    DEVANE, J
    NEUROLOGY, 1992, 42 (07) : 1427 - 1427
12345